PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the ...

A consortium led by French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health ...

PARIS (Reuters) -French drugmaker Sanofi said on Thursday it was "surprised" by a renewed, higher offer for its consumer arm ...

Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...

PAI Partners raises offer for Sanofi's consumer health unit, Opella, by €200 million and aims to keep key operations in ...

Operating independently within Sanofi, Opella has resources allocated for research and development, production, and digital ...

PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year.

A consortium led by French private equity firm PAI Partners has submitted an increased offer for Sanofi's (SASY) consumer health ...

PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the matter, an unexpected twist in one of the biggest deals in Europe this year.

Sanofi announced on Monday that it had entered into exclusive negotiations with US investment fund CD&R to sell it a majority ...

PAI Partners increased its offer for Sanofi's (NASDAQ:SNY) consumer health unit. The private equity shop raised its offer by about €200 million ($217 million) for the Opella business and pledged ...